Marc Guillaume Denis (Marc G Denis, Marc Denis)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 10

Top Venues

Cancers

Journal of clinical medicine

Current oncology (Toronto, Ont.)

BMC research notes

This page only lists publications with an associated author ORCID identifier.

Publications

Laurent Mathiot, Guillaume Herbreteau, Siméon Robin, Charlotte Fenat, Jaafar Bennouna, Christophe Blanquart, Marc Guillaume Denis, Elvire Pons-Tostivint
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature. Current oncology (Toronto, Ont.) 29 (5) (2022)
Alexis B Cortot, Anne Madroszyk, Etienne Giroux-Leprieur, Olivier Molinier, Elisabeth Quoix, Henri Bérard, Josiane Otto, Isabelle Rault, Denis Moro-Sibilot, Judith Raimbourg, Elodie Amour, Franck Morin, José Hureaux, Lionel Moreau, Didier Debieuvre, Hugues Morel, Aldo Renault, Eric Pichon, Benjamin Huret, Sandrine Charpentier, Marc Guillaume Denis, Jacques Cadranel
First-Line Afatinib plus Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Guillaume Herbreteau, Fabrice Airaud, Elise Pierre-Noël, Audrey Vallée, Stéphane Bézieau, Sandrine Théoleyre, Hélène Blons, Simon Garinet, Marc Guillaume Denis
MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal Cancer. Cancers 13 (16) (2021)
Elvire Pons-Tostivint, Alexandre Lugat, Jean-François Fonteneau, Marc Guillaume Denis, Jaafar Bennouna
STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact. Cells 10 (11) (2021)
Guillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, Sandrine Théoleyre, Gaëlle Quéreux, Emilie Varey, Amir Khammari, Brigitte Dréno, Marc Guillaume Denis
Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study. Cancers 13 (8) (2021)
Guillaume Herbreteau, Alexandra Langlais, Laurent Greillier, Clarisse Audigier-Valette, Lionel Uwer, José Hureaux, Denis Moro-Sibilot, Florian Guisier, Delphine Carmier, Jeannick Madelaine, Josiane Otto, Pierre-Jean Souquet, Valérie Gounant, Patrick Merle, Olivier Molinier, Aldo Renault, Audrey Rabeau, Franck Morin, Marc Guillaume Denis, Jean-Louis Pujol
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab. Journal of clinical medicine 9 (12) (2020)
Guillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, Sandrine Théoleyre, Gaelle Quéreux, Cécile Frénard, Emilie Varey, Paul Hofman, Amir Khammari, Brigitte Dréno, Marc Guillaume Denis
Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients. Cancers 12 (7) (2020)
Audrey Vallée, Marie Denis-Musquer, Guillaume Herbreteau, Sandrine Théoleyre, Céline Bossard, Marc Guillaume Denis
Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay. PloS one 14 (8) (2019)
Guillaume Herbreteau, Sandrine Charpentier, Audrey Vallée, Marc Guillaume Denis
Use of circulating tumoral DNA to guide treatment for metastatic melanoma. Pharmacogenomics 20 (18) (2019)
Gaelle Quéreux, Guillaume Herbreteau, Anne-Chantal Knol, Audrey Vallée, Amir Khammari, Sandrine Théoleyre, Mélanie Saint-Jean, Brigitte Dréno, Marc Guillaume Denis
Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report. BMC research notes 10 (1) (2017)

Marc Guillaume Denis.css-eqlu8i{font-size:small;padding-left:4px;} (Marc G Denis, Marc Denis)

Publication Activity (10 Years)

Top Topics

Top Venues

Marc Guillaume Denis (Marc G Denis, Marc Denis)